In January 2011, it was granted accelerated review by the EMA and received a positive opinion in July 2011. If approved, the drug will be marketed under the trade name Incivo in Europe.
-
Incivek (telaprevir) is a protease inhibitor used for treatming Hepatitis C... -
Vertex Pharmaceuticals is developing the drug in collaboration with the... -
In January 2011, it was granted accelerated review by the EMA and received a...
